Pyrrolo [2, 3 -D] pyrimidin derivatives as protein kinase B inhibitors

Details for Australian Patent Application No. 2008309383 (hide)

Owner AstraZeneca AB

Inventors Morris, Jeffrey James; Johnson, Paul David; Leach, Andrew; Matusiak, Zbigniew Stanley; Luke, Richard William Arthur

Agent Davies Collison Cave

Pub. Number AU-B-2008309383

PCT Pub. Number WO2009/047563

Priority 60/979,192 11.10.07 US; 61/047,862 25.04.08 US

Filing date 9 October 2008

Wipo publication date 16 April 2009

Acceptance publication date 19 April 2012

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

15 April 2010 PCT application entered the National Phase

  PCT publication WO2009/047563 Priority application(s): WO2009/047563

19 April 2012 Application Accepted

  Published as AU-B-2008309383

26 July 2012 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to read Luke, Richard William Arthur and Matusiak, Zbigniew Stanley . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008309385-Zibotentan composition containing mannitol and/or microcrystalline cellulose

2008309380-A packaging system